Educational Symposium
Mechanisms and Advances in ANCA-Associated Vasculitis
October 24, 2024 | 12:45 PM - 01:45 PM
Location: TBD, Marriott Marquis
Session Description
ANCA-associated vasculitis is an autoimmune disease affecting small blood vessels in the body. With evolving new non-immunosuppressive therapies, B cell depletion, and recent FDA approval of complement blockers as adjunctive therapy for severe active ANCA-associated vasculitis, it is an important time to consider mechanisms involved to improve patient safety concerns with the current standard of care over time. This symposium reviews the pathophysiology of ANCA-associated vasculitis and discusses emerging therapies in treating ANCA-associated vasculitis.
This activity is supported by educational funding provided by Amgen.
Learning Objective(s)
- Summarize the unmet needs in the current standard of care and complications of ANCA-associated vasculitis based on current guidelines
- Describe new therapies for the treatment and management of ANCA-associated vasculitis
Learning Pathway(s)
- Glomerular Diseases
- Pathology
Moderator
Presentations
- Introduction
12:45 PM - 12:55 PM
- Treatment of ANCA-Associated Vasculitis
12:55 PM - 01:15 PM
- The Role of Endothelin in ANCA-Associated Vasculitis
01:15 PM - 01:35 PM
- Audience Q&A
01:35 PM - 01:45 PM